Market Overview

Sterne Agee Reiterates Buy Rating, $20 PT on Denbury Resources

Share:
Related DNR
Mid-Afternoon Market Update: Arrowhead Pharma Tumbles Following EX-1 RNAi Program Discontinuations; Arbutus Biopharma Shares Surge
18 Biggest Mid-Day Gainers For Wednesday

In a report published Wednesday, Sterne Agee Group reiterated its Buy rating and $20.00 price target on Denbury Resources (NYSE: DNR).

Sterne Agee noted, “Denbury announced it closed its Bakken sale/swap on Monday. With final figures emerging, we are increasingly positive on the deal. Denbury received ownership of producing CO2 properties, providing optionality on the timing of CO2 spending at Riley Ridge, and setting a tax leakage ceiling at ~$400 million. With the Greencore Pipeline completed on schedule, Denbury's Rockies' development continues to gain momentum. We reiterate our Buy rating and $20 PT.”

Denbury Resources closed on Monday at $16.29.

Latest Ratings for DNR

DateFirmActionFromTo
Aug 2016BarclaysDowngradesEqual-WeightUnderweight
Jun 2016Stifel NicolausUpgradesSellHold
Apr 2016KeyBancInitiates Coverage onSector Perform

View More Analyst Ratings for DNR
View the Latest Analyst Ratings

Posted-In: Sterne Agee GroupAnalyst Color Reiteration Analyst Ratings

 

Related Articles (DNR)

View Comments and Join the Discussion!